Ontario Welcomes $6.3 Million Life Sciences Investment in Mississauga
Eurofins CDMO Alphora will expand research capabilities and create well-paying jobs
MISSISSAUGA – The Ontario government is supporting a $6.3 million investment by Eurofins Alphora, a subsidiary of Eurofins Scientific, a global leader in bio-analysis. This investment will support cutting-edge innovation in the life sciences sector and create well-paying jobs in Mississauga. To support this investment, the government is providing Eurofins with $2.5 million through the Ontario Together Fund (OTF).
Rudy Cuzzetto, MPP for Mississauga—Lakeshore, and Effie Triantafilopoulos, Parliamentary Assistant to the Minister of Economic Development, Job Creation and Trade joined Geoff Evans, President, Eurofins CDMO Alphora Inc. to announce Eurofins’ investment today.
“Mississauga is a leading life science hub in Canada because of firms like Eurofins Alphora, and I am so happy that the Province is supporting Eurofins as it invests in new biologics capabilities, including a new laboratory,” said MPP Cuzzetto. “When this new 3,200 square foot facility opens later this year, it will help to expand the market reach of Eurofins to new clients across the life sciences sector, and create good, well-paying local jobs in Mississauga. And I know the OTF will continue to support homegrown life sciences technology and innovation to build Ontario’s manufacturing capacity for goods and services that are critical to the health, safety, and security of all Ontarians.”
“Today, we celebrate a significant partnership that’s poised to drive innovation in Ontario’s life sciences sector,” said PA Triantafilopoulos. “With the Ontario government’s support, Eurofins Alphora, a subsidiary of the esteemed Eurofins Scientific, is making a $6.3 million investment that will not only propel groundbreaking research but also foster the creation of high-quality jobs in Mississauga. This collaboration underscores our commitment to advancing scientific excellence and economic prosperity in the province. Through the OTF, we’re proud to contribute $2.5 million towards this transformative endeavor, symbolizing our dedication to a brighter, more innovative future for Ontario.”
Eurofins is investing $6.3 million to purchase specialized equipment and machinery and create a new pharmaceutical development laboratory. The laboratory will be used to expand Eurofins CDMO Alphora’s offerings for pharmaceutical development and pre-clinical studies of biological therapeutics such as antibodies and proteins to clients in the Canadian life sciences sector and abroad. Together, the joint investment by Eurofins and the Ontario Government through the OTF will also support skilled training for workers and create six well-paying, technical jobs in the life sciences sector.
The OTF provides financial support to organizations with projects geared towards advancing health-care resiliency, with a focus on developing innovative medical technologies and reducing dependence on foreign supply chains for essential lifesaving medicines. The fund provides investments in capital equipment, technology adoption and skills development.
“Through the OTF, we continue to grow our life sciences sector and help Ontario businesses innovate and bring their ideas to market,” said Vic Fedeli, Minister of Economic Development, Job Creation and Trade. “Thank you, Eurofins CDMO Alphora, for helping to make Ontario home to the next generation of medical technology solutions.”
- Over the past three years, life sciences companies and global biomanufacturers have invested over $3 billion in Ontario.
- Ontario’s life sciences sector generates more than $65 billion in revenue annually.The sector also exports $11 billion in goods annually, representing 62 per cent of total Canadian life sciences exports.
- To support the next phase of Taking Life Sciences to the Next Level, Ontario’s life sciences strategy, the province has established a Life Sciences Council. The council will explore ways to support the creation of well-paying jobs, accelerate commercialization and encourage the adoption of Ontario-made innovations to improve health-care and grow the economy.